Enhanced susceptibility of HLA-mediated ticlopidine-induced idiosyncratic hepatotoxicity by CYP2B6 polymorphism in Japanese

Noritaka Ariyoshi, Yukako Iga, Koji Hirata, Yasunori Sato, Go Miura, Itsuko Ishii, Seiji Nagamori, Mitsukazu Kitada

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Hepatotoxicity is the most frequent adverse drug reaction (ADR) in Japanese treated with ticlopidine (TP). We investigated the relationship between CYP2B6 haplotype and incidence of TP-induced hepatotoxicity in 114 Japanese patients. Although 4 haplotypes (*1A, *1H, *1J and *6B) accounted for more than 80z of the inferred haplotypes in both control (n=81) and case (n=22) subjects, the prevalence was apparently different: control, *1AA>*6BA>*1HA>*1J and case, *1JA>*1HA>*1AA>*6B. The reporter gene assay for the two SNPs, which comprise the *1H or *1J haplotype, suggested that the *1H and *1J haplotypes may be associated with the increased expression of CYP2B6, probably due to g.-2320TÀC. Combination analysis of CYP2B6 and human leukocyte antigen (HLA) haplotypes revealed that individuals possessing CYP2B6*1H or *1J with HLA-A*3303 have the highest susceptibility to TP-induced hepatotoxicity (odds ratio, 38.82;95zCI, 8.08-196.0, Po0.001). Although this is a preliminary case-control study with some limitations, it is the first example that HLA-induced idiosyncratic ADR may be modified by individual variation in CYP activities.

Original languageEnglish
Pages (from-to)298-306
Number of pages9
JournalDrug Metabolism and Pharmacokinetics
Volume25
Issue number3
DOIs
Publication statusPublished - 2010
Externally publishedYes

Fingerprint

Ticlopidine
HLA Antigens
Haplotypes
Drug-Related Side Effects and Adverse Reactions
Reporter Genes
Single Nucleotide Polymorphism
Cytochrome P-450 CYP2B6
Case-Control Studies
Odds Ratio
Incidence

Keywords

  • CYP2B6
  • Haplotype
  • HLA
  • Interethnic difference
  • Metabolic activation
  • Ticlopidine-induced hepatotoxicity

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology
  • Pharmaceutical Science
  • Medicine(all)

Cite this

Enhanced susceptibility of HLA-mediated ticlopidine-induced idiosyncratic hepatotoxicity by CYP2B6 polymorphism in Japanese. / Ariyoshi, Noritaka; Iga, Yukako; Hirata, Koji; Sato, Yasunori; Miura, Go; Ishii, Itsuko; Nagamori, Seiji; Kitada, Mitsukazu.

In: Drug Metabolism and Pharmacokinetics, Vol. 25, No. 3, 2010, p. 298-306.

Research output: Contribution to journalArticle

Ariyoshi, Noritaka ; Iga, Yukako ; Hirata, Koji ; Sato, Yasunori ; Miura, Go ; Ishii, Itsuko ; Nagamori, Seiji ; Kitada, Mitsukazu. / Enhanced susceptibility of HLA-mediated ticlopidine-induced idiosyncratic hepatotoxicity by CYP2B6 polymorphism in Japanese. In: Drug Metabolism and Pharmacokinetics. 2010 ; Vol. 25, No. 3. pp. 298-306.
@article{9f7d9bfb9a004fbf9e3b59592583b498,
title = "Enhanced susceptibility of HLA-mediated ticlopidine-induced idiosyncratic hepatotoxicity by CYP2B6 polymorphism in Japanese",
abstract = "Hepatotoxicity is the most frequent adverse drug reaction (ADR) in Japanese treated with ticlopidine (TP). We investigated the relationship between CYP2B6 haplotype and incidence of TP-induced hepatotoxicity in 114 Japanese patients. Although 4 haplotypes (*1A, *1H, *1J and *6B) accounted for more than 80z of the inferred haplotypes in both control (n=81) and case (n=22) subjects, the prevalence was apparently different: control, *1AA>*6BA>*1HA>*1J and case, *1JA>*1HA>*1AA>*6B. The reporter gene assay for the two SNPs, which comprise the *1H or *1J haplotype, suggested that the *1H and *1J haplotypes may be associated with the increased expression of CYP2B6, probably due to g.-2320T{\`A}C. Combination analysis of CYP2B6 and human leukocyte antigen (HLA) haplotypes revealed that individuals possessing CYP2B6*1H or *1J with HLA-A*3303 have the highest susceptibility to TP-induced hepatotoxicity (odds ratio, 38.82;95zCI, 8.08-196.0, Po0.001). Although this is a preliminary case-control study with some limitations, it is the first example that HLA-induced idiosyncratic ADR may be modified by individual variation in CYP activities.",
keywords = "CYP2B6, Haplotype, HLA, Interethnic difference, Metabolic activation, Ticlopidine-induced hepatotoxicity",
author = "Noritaka Ariyoshi and Yukako Iga and Koji Hirata and Yasunori Sato and Go Miura and Itsuko Ishii and Seiji Nagamori and Mitsukazu Kitada",
year = "2010",
doi = "10.2133/dmpk.25.298",
language = "English",
volume = "25",
pages = "298--306",
journal = "Drug Metabolism and Pharmacokinetics",
issn = "1347-4367",
publisher = "Japanese Society for the Study of Xenobiotics",
number = "3",

}

TY - JOUR

T1 - Enhanced susceptibility of HLA-mediated ticlopidine-induced idiosyncratic hepatotoxicity by CYP2B6 polymorphism in Japanese

AU - Ariyoshi, Noritaka

AU - Iga, Yukako

AU - Hirata, Koji

AU - Sato, Yasunori

AU - Miura, Go

AU - Ishii, Itsuko

AU - Nagamori, Seiji

AU - Kitada, Mitsukazu

PY - 2010

Y1 - 2010

N2 - Hepatotoxicity is the most frequent adverse drug reaction (ADR) in Japanese treated with ticlopidine (TP). We investigated the relationship between CYP2B6 haplotype and incidence of TP-induced hepatotoxicity in 114 Japanese patients. Although 4 haplotypes (*1A, *1H, *1J and *6B) accounted for more than 80z of the inferred haplotypes in both control (n=81) and case (n=22) subjects, the prevalence was apparently different: control, *1AA>*6BA>*1HA>*1J and case, *1JA>*1HA>*1AA>*6B. The reporter gene assay for the two SNPs, which comprise the *1H or *1J haplotype, suggested that the *1H and *1J haplotypes may be associated with the increased expression of CYP2B6, probably due to g.-2320TÀC. Combination analysis of CYP2B6 and human leukocyte antigen (HLA) haplotypes revealed that individuals possessing CYP2B6*1H or *1J with HLA-A*3303 have the highest susceptibility to TP-induced hepatotoxicity (odds ratio, 38.82;95zCI, 8.08-196.0, Po0.001). Although this is a preliminary case-control study with some limitations, it is the first example that HLA-induced idiosyncratic ADR may be modified by individual variation in CYP activities.

AB - Hepatotoxicity is the most frequent adverse drug reaction (ADR) in Japanese treated with ticlopidine (TP). We investigated the relationship between CYP2B6 haplotype and incidence of TP-induced hepatotoxicity in 114 Japanese patients. Although 4 haplotypes (*1A, *1H, *1J and *6B) accounted for more than 80z of the inferred haplotypes in both control (n=81) and case (n=22) subjects, the prevalence was apparently different: control, *1AA>*6BA>*1HA>*1J and case, *1JA>*1HA>*1AA>*6B. The reporter gene assay for the two SNPs, which comprise the *1H or *1J haplotype, suggested that the *1H and *1J haplotypes may be associated with the increased expression of CYP2B6, probably due to g.-2320TÀC. Combination analysis of CYP2B6 and human leukocyte antigen (HLA) haplotypes revealed that individuals possessing CYP2B6*1H or *1J with HLA-A*3303 have the highest susceptibility to TP-induced hepatotoxicity (odds ratio, 38.82;95zCI, 8.08-196.0, Po0.001). Although this is a preliminary case-control study with some limitations, it is the first example that HLA-induced idiosyncratic ADR may be modified by individual variation in CYP activities.

KW - CYP2B6

KW - Haplotype

KW - HLA

KW - Interethnic difference

KW - Metabolic activation

KW - Ticlopidine-induced hepatotoxicity

UR - http://www.scopus.com/inward/record.url?scp=77954279332&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954279332&partnerID=8YFLogxK

U2 - 10.2133/dmpk.25.298

DO - 10.2133/dmpk.25.298

M3 - Article

C2 - 20610889

AN - SCOPUS:77954279332

VL - 25

SP - 298

EP - 306

JO - Drug Metabolism and Pharmacokinetics

JF - Drug Metabolism and Pharmacokinetics

SN - 1347-4367

IS - 3

ER -